Vitamin K2 Market Report by Product, Dosage Form, Source, Application, Distribution Channel, Countries and Companies Analysis 2026-2034

Vitamin K2 market is projected to experience strong growth over the forecast period, expanding from US$ 275.20 billion in 2025 to US$ 909.17 billion by 2034. This growth reflects a steady Compound Annual Growth Rate (CAGR) of 14.20% during 2026-2034. The expansion is driven by rising awareness of bone and cardiovascular health, increasing demand for preventive healthcare solutions, and growing adoption of nutraceuticals and functional foods. Advancements in product formulations and expanding global distribution channels are further supporting market growth.

Global Vitamin K2 Industry Overview

Vitamin K2 is a fat-soluble vitamin that belongs to the vitamin K family and plays a crucial role in regulating calcium metabolism in the human body. Unlike vitamin K1, which primarily supports blood clotting, vitamin K2 helps activate proteins that direct calcium toward bones and teeth while preventing its accumulation in arteries and soft tissues. This dual action makes it highly important for maintaining both skeletal strength and cardiovascular health. Vitamin K2 is naturally found in fermented foods such as natto, cheese, and certain animal-based products, and it is also widely available in supplement form, particularly as MK-7 and MK-4 variants.

Globally, vitamin K2 is gaining significant popularity due to rising awareness of preventive healthcare and long-term wellness. It is commonly used to support bone density, reduce the risk of osteoporosis, and improve heart health by preventing arterial calcification. The growing aging population, increasing prevalence of lifestyle-related diseases, and rising interest in functional foods and nutraceuticals have further boosted its demand worldwide. Additionally, scientific research and health campaigns promoting its benefits are driving consumer acceptance, making vitamin K2 one of the fastest-growing nutrients in the global dietary supplement industry.

The alarming rise of lifestyle diseases and their impact on public health

Diabetes

• Approximately 537 million adults worldwide (1 in 10 adults) are living with diabetes.
• The number of people with diabetes is projected to reach 783 million by 2045.
• More than 75% of diabetes patients reside in low- and middle-income countries.
• Diabetes was responsible for approximately 6.7 million deaths in 2021.
• Global healthcare spending on diabetes reached USD 966 billion in 2021, representing a 316% increase over the past 15 years.
• Around 541 million adults have impaired glucose tolerance, placing them at high risk of developing type 2 diabetes.
• Diabetes contributes significantly to cardiovascular disease, kidney failure, blindness, and reduced quality of life.

Cardiovascular Diseases (CVDs)

• Cardiovascular diseases caused 17.9 million deaths globally in 2019, accounting for 32% of all deaths worldwide.
• Approximately 85% of CVD-related deaths result from heart attacks and strokes.
• More than 75% of cardiovascular deaths occur in low- and middle-income countries.
• Ischemic heart disease and stroke remain the leading causes of cardiovascular mortality worldwide.
• The global economic burden of cardiovascular diseases is projected to reach USD 1 trillion annually by 2030.
• CVDs place substantial pressure on healthcare systems and contribute to disability, reduced productivity, and premature mortality.

Obesity

• In 2022, approximately 890 million adults (1 in 8 adults) worldwide were classified as obese.
• Around 2.5 billion adults were overweight globally.
• Childhood obesity affected approximately 37 million children under 5 years and more than 390 million children and adolescents aged 5-19 years.
• By 2035, nearly 3 billion people are expected to be overweight or obese.
• The highest growth rates are anticipated in low- and middle-income countries.
• The global economic impact of obesity is estimated at USD 2 trillion annually, comparable to the economic costs of smoking and armed conflict.
• Obesity significantly increases the risk of diabetes, cardiovascular disease, cancer, and other chronic illnesses.

Mental Health Disorders

• More than 264 million people worldwide suffer from depression.
• Approximately 284 million people globally live with anxiety disorders.
• Mental health conditions affect over 1 billion people worldwide.
• Around 800,000 people die by suicide each year.
• Suicide is the second leading cause of death among individuals aged 15-29 years.
• Mental health disorders contribute significantly to disability, social challenges, and reduced quality of life.
• The global economy loses approximately USD 1 trillion annually due to reduced productivity associated with mental health conditions.
• Growing prevalence highlights the need for improved mental health awareness, prevention, and access to care.

Top Vitamin K2 Product Launches Worldwide

No. Product Launch Company Launch Year Description

• K2Vital MCT Organic Kappa Bioscience 2022 First USDA Organic-certified Vitamin K2 MK-7 ingredient for oil-based supplements, targeting the growing organic nutrition market. (Nutritional Outlook)
• MenaQ7 Metabolic Gnosis by Lesaffre & SunWay Biotech 2024 A metabolic health formulation combining MenaQ7 Vitamin K2 MK-7 with ANKASCIN® 568-R to support cardiovascular and metabolic wellness. (Pubs - Clinical Research News Online)
• MenaQ7 Full Spectrum K2 NattoPharma (Gnosis by Lesaffre) 2024 Introduced as the first full-spectrum Vitamin K2 ingredient containing MK-6, MK-7, MK-8, and MK-9 forms. (Nutraceuticals World)
• MenaQ7 Protect Gnosis by Lesaffre 2023 Private-label immune support supplement combining Vitamin K2 MK-7, probiotics, and Vitamin C. (Nutraceuticals World)
• Omega-3 with Vitamin K2 Wiley's Finest 2024 High-potency Omega-3 supplement formulated with MenaQ7 Vitamin K2 MK-7 for heart and bone health support. (Nutraceuticals World)
• Matrix-Protected MenaQ7 MK-7 Gnosis by Lesaffre 2024 Advanced matrix-protected Vitamin K2 ingredient designed to improve stability and shelf life in supplement formulations. (Nutraceuticals World)
• K2VITAL White-Label Product Range Kappa Bioscience 2024 Launch of multiple ready-to-market Vitamin K2 products in innovative delivery formats through the ExperienceCard program. (Nutraceuticals World)
• MenaQ7 Natural Vitamin K2 as MK-7 Gnosis by Lesaffre 2023 Repositioned and relaunched with expanded health positioning beyond bone and cardiovascular benefits. (Nutraceutical Business Review)
• K2Vital Organic Ingredient Platform Kappa Bioscience 2022 Expanded organic Vitamin K2 ingredient portfolio for supplement and functional food manufacturers. (Nutritional Outlook)
• MenaQ7 Sustainable Vitamin K2 Platform MenaQ7 2024 New sustainability-focused Vitamin K2 ingredient platform emphasizing natural sourcing and clinical validation. (Menaq7)

Growth Driver of the Vitamin K2 Market

Rising Awareness of Bone and Heart Health

By 2050 globally, there will be up to 21.3 million hip fractures each year. In 2023, 919,032 people died from cardiovascular disease. That's the equivalent of 1 in every 3 deaths. Vitamin K2 plays an essential role in regulating calcium metabolism by activating proteins that help direct calcium into bones while preventing its accumulation in arteries. As awareness of chronic health conditions such as osteoporosis and cardiovascular disease continues to grow, consumers are increasingly recognizing the preventive and therapeutic value of vitamin K2. Healthcare professionals and supplement manufacturers are actively promoting its benefits for maintaining strong bones and supporting heart health. Additionally, rising exposure through public health campaigns, scientific studies, and media discussions is further improving consumer understanding of long-term wellness advantages associated with vitamin K2. This growing awareness is encouraging individuals to adopt proactive health management approaches, particularly those focused on maintaining bone density, cardiovascular efficiency, and overall mobility. As a result, demand for vitamin K2-based supplements is steadily increasing, driven by the shift toward natural, preventive, and nutrition-based healthcare solutions.

Aging Global Population

By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time, the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. The expansion of the global elderly population is significantly contributing to the growth of the vitamin K2 market. Aging individuals are more vulnerable to bone degeneration, fractures, and cardiovascular complications, conditions in which vitamin K2 has demonstrated supportive benefits. This demographic shift is increasing demand for nutritional supplements that enhance longevity and improve quality of life. Older adults are particularly focused on maintaining bone strength and preventing arterial calcification, both of which are influenced by adequate vitamin K2 levels in the body. With the rising emphasis on healthy aging and preventive healthcare, vitamin K2 is gaining recognition as an important nutrient for age-related wellness. This trend is also encouraging manufacturers to develop targeted formulations designed specifically for senior consumers. As life expectancy increases globally, the need for effective, safe, and long-term nutritional support solutions such as vitamin K2 continues to rise steadily.

Increased Use in Functional Foods and Nutraceuticals

Vitamin K2 is increasingly being incorporated into functional foods and nutraceutical products beyond traditional supplement formats. Consumers are showing strong preference for convenient, food-based nutrition solutions such as fortified dairy products, energy bars, and beverages that integrate health benefits into daily diets. This shift is largely driven by busy lifestyles and a growing focus on preventive healthcare and wellness-oriented eating habits. In response, food and beverage manufacturers are innovating by adding bioactive ingredients like vitamin K2 to enhance nutritional value without requiring separate supplement intake. The MK-7 form of vitamin K2, known for its stability and high bioavailability, is particularly suitable for such applications. This versatility is expanding its use across multiple product categories. As consumer demand for functional nutrition continues to grow, vitamin K2 is becoming a key ingredient supporting innovation and long-term market expansion in the health-focused food industry. In March 2026, AstaReal AB introduced a vegan vitamin D3+K2 supplement made from lichen, a natural and sustainable alternative to the animal-derived lanolin.

Challenges in the Vitamin K2 Market

Limited Consumer Awareness

One of the major challenges restricting the growth of the vitamin K2 market is the relatively low level of consumer awareness regarding its specific health benefits. Although research highlights its importance in calcium regulation, bone strengthening, and cardiovascular protection, vitamin K2 remains less recognized compared to more established vitamins such as vitamin C and vitamin D. Additionally, many consumers mistakenly confuse vitamin K2 with vitamin K1, which primarily supports blood clotting and does not provide the same benefits for bone and arterial health. This lack of clarity creates barriers for effective education and communication by healthcare professionals and supplement brands. As a result, demand growth is slower than expected. Bridging this knowledge gap through medical guidance, awareness campaigns, and clearer product labeling is essential to improving consumer understanding and increasing adoption of vitamin K2-based products in the global nutrition market.

High Production Costs

The production of vitamin K2 involves complex and highly controlled fermentation processes, particularly for the MK-7 variant, which is known for its superior bioavailability. These manufacturing methods require precise environmental conditions, extended fermentation cycles, and strict quality assurance measures to ensure product purity, potency, and stability. Additionally, maintaining long shelf life and functional effectiveness under varying storage conditions further increases production complexity. As a result, overall manufacturing costs remain high compared to many other vitamin products. These elevated costs are often transferred to consumers, making vitamin K2 supplements relatively expensive in the marketplace. Consequently, affordability becomes a major limitation, especially in price-sensitive and developing regions. The lack of cost-efficient large-scale production technologies further restricts widespread accessibility. Until more economical manufacturing solutions are developed, high production costs will continue to pose a significant challenge to broader market expansion and adoption of vitamin K2 products.

Vitamin MK-4 Market

The Vitamin MK-4 market is driven by its important role in bone health, cardiovascular support, and hormonal balance. MK-4, a short-chain form of vitamin K2, is widely used in pharmaceutical applications due to its rapid absorption and effectiveness in bone metabolism regulation. It is commonly prescribed in certain countries for osteoporosis treatment and prevention of age-related bone disorders. Increasing cases of bone density loss, especially among the elderly population, are supporting its demand. Additionally, growing awareness of calcium management and arterial health is encouraging broader adoption. However, MK-4 requires higher and more frequent dosing compared to MK-7, which can limit its convenience. Despite this, ongoing research and clinical use continue to support its relevance in medical nutrition. Expanding healthcare infrastructure and rising focus on preventive treatments are further strengthening the MK-4 segment, particularly in Asia and select European pharmaceutical markets.

Capsules & Tablets Vitamin K2 Market

The capsules and tablets segment dominates the Vitamin K2 market due to its convenience, precise dosing, and widespread consumer acceptance. These solid oral dosage forms are preferred for daily supplementation as they are easy to consume, portable, and offer longer shelf stability. Capsules, especially soft gels, enhance the absorption of fat-soluble vitamin K2, improving its effectiveness in supporting bone and cardiovascular health. Tablets, on the other hand, provide cost-effective production and wide availability across pharmacies and retail stores. Increasing consumer preference for preventive healthcare and self-supplementation is driving strong demand in this segment. Additionally, pharmaceutical and nutraceutical companies are introducing advanced formulations combining Vitamin K2 with vitamin D3 and calcium for better health outcomes. Rising awareness of osteoporosis prevention and heart health maintenance is further fueling market growth. Overall, this segment remains the most accessible and commercially significant delivery form in the global Vitamin K2 industry.

Natural Vitamin K2 Market

The natural Vitamin K2 market is expanding rapidly as consumers increasingly prefer clean-label, non-synthetic, and food-derived nutritional products. Natural Vitamin K2 is typically sourced from fermented foods such as natto, cheese, and certain animal-based products, making it more appealing to health-conscious and organic-focused consumers. Rising awareness about chemical-free supplements and sustainable nutrition is strongly supporting demand in this segment. The MK-7 form derived from natural fermentation is particularly popular due to its high bioavailability and longer half-life in the body. Additionally, growing vegan and vegetarian trends are encouraging manufacturers to develop plant-based fermentation processes to meet dietary preferences. The increasing popularity of functional foods and nutraceuticals is also boosting incorporation of natural Vitamin K2 into fortified products. However, higher production costs and limited raw material availability can restrict large-scale adoption. Despite this, strong consumer trust in natural ingredients continues to drive steady global growth of this segment.

Vitamin K2 Online Market

The Vitamin K2 online market is growing significantly due to the rapid expansion of e-commerce platforms and increasing digital health awareness. Consumers are increasingly purchasing dietary supplements through online channels because of convenience, wider product selection, and competitive pricing. Online platforms also provide access to global brands, customer reviews, and detailed product information, helping buyers make informed decisions. The rising trend of direct-to-consumer (DTC) supplement brands is further accelerating online sales of Vitamin K2 products. Mobile shopping apps and digital marketing strategies, including influencer promotions and health content, are also boosting visibility and consumer engagement. Additionally, the COVID-19 pandemic has permanently shifted consumer behavior toward online health and wellness purchases. Subscription-based supplement models and doorstep delivery services are further enhancing user convenience. However, concerns regarding product authenticity and quality control remain challenges. Despite this, the online segment continues to be one of the fastest-growing distribution channels for Vitamin K2 globally.

United States Vitamin K2 Market

The vitamin K2 market in the United States is witnessing consistent growth, driven by increasing consumer awareness of its essential role in supporting bone strength and cardiovascular health. The rising preference for preventive healthcare and natural wellness solutions is further accelerating demand. Consumers are becoming more informed about vitamin K2’s ability to support calcium metabolism and improve vascular health, particularly as they focus on healthy aging and long-term disease prevention. The market benefits from a well-established nutraceutical industry, wide product availability across retail and online channels, and continuous innovation in supplement formulations, including fortified foods and advanced delivery systems. However, challenges such as limited public understanding and relatively high product pricing continue to restrict broader adoption. Despite these limitations, growing health education efforts and increasing interest in holistic wellness are expected to significantly enhance market penetration and consumer acceptance in the coming years. A major development supporting market expansion was the introduction of the first USDA organic-certified vitamin K2-MK7 by Kappa Bioscience under its K2Vital brand in October 2022. This innovation, designed specifically for oil-based supplement formulations, has enabled manufacturers to develop higher-quality organic products. It has also strengthened opportunities for entry into the rapidly growing organic health and wellness segment, further supporting long-term market growth in the United States.

United Kingdom Vitamin K2 Market

The vitamin K2 market in the United Kingdom is steadily expanding due to rising awareness of its benefits for bone maintenance and cardiovascular health. Increasing concerns related to osteoporosis and heart disease, combined with a growing elderly population, are driving demand for preventive healthcare supplements. Consumers are increasingly shifting toward natural and plant-based nutritional products, which is further boosting interest in vitamin K2 derived from clean-label sources. The market offers a diverse range of formulations, including MK-7 and MK-4 variants, catering to different health needs and consumer preferences. Ongoing advancements in product delivery systems and formulations are also improving absorption, convenience, and user compliance. However, growth is somewhat constrained by limited public awareness and relatively high supplement costs. Despite these challenges, rising health education initiatives and a strong focus on preventive wellness are expected to continue supporting steady market expansion in the UK.

India Vitamin K2 Market

The vitamin K2 market in India is experiencing rapid growth, supported by increasing awareness of its health benefits, particularly in relation to bone strength and cardiovascular wellness. Rising cases of osteoporosis and heart-related conditions, along with a growing elderly population, are encouraging greater adoption of preventive healthcare solutions. Consumers are increasingly seeking natural and plant-based supplements, contributing to higher demand for vitamin K2 products derived from clean and herbal sources. The expanding nutraceutical industry, improved retail distribution networks, and continuous innovation in fortified foods and dietary supplements are further strengthening market growth. However, widespread adoption is still limited by low consumer awareness and relatively high product costs. Despite these challenges, ongoing educational campaigns, rising health consciousness, and a shift toward holistic wellness approaches are expected to significantly enhance market visibility and drive long-term growth in India’s vitamin K2 sector.

United Arab Emirates Vitamin K2 Market

The vitamin K2 market in the United Arab Emirates (UAE) is growing steadily, driven by increasing awareness of its benefits for bone health and cardiovascular protection. Rising prevalence of lifestyle-related disorders such as heart disease and osteoporosis, along with a growing aging population, is fueling demand for preventive health supplements. Consumers in the UAE are increasingly adopting plant-based and natural nutritional products, supporting the popularity of vitamin K2-based formulations. The market is supported by a strong nutraceutical sector, expanding retail and online availability, and continuous innovation in fortified foods and supplement formats. Despite this growth momentum, challenges such as limited public awareness and relatively high product pricing continue to restrict broader adoption. Nevertheless, increasing health education efforts, rising disposable incomes, and a strong shift toward preventive healthcare and wellness-focused lifestyles are expected to support steady market expansion in the UAE over the coming years.

Market Segmentations

Product

• MK-7
• MK-4

Dosage Form

• Powder & Crystalline
• Capsules & Tablets
• Oils & Liquid

Source

• Natural
• Synthetic

Application

• Health Supplements
• Functional Foods and Beverages

Distribution Channel

• Offline
• Online

Countries

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

All the Key players have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• NOW Foods
• Life Extension
• Nestlé
• Bronson
• NatureWise
• Solaray
• Natural Factors
• Source Naturals